Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **peripheral nociceptor** is a specialized sensory neuron located in the peripheral nervous system that detects potentially harmful mechanical, thermal, or chemical stimuli and initiates signals interpreted as pain by the central nervous system.[1][3] These neurons have free nerve endings distributed throughout skin, muscle, joints, bone and viscera.[6] They express a variety of transducer molecules—most notably members of the transient receptor potential (TRP) family such as **TRPV1** and **TRPA1**, acid-sensing ion channels (**ASICs**), purinergic receptors (**P2X3**), among others—that enable them to respond selectively to different types of noxious input.[5][8] Nociceptors are classified based on conduction velocity into myelinated Aδ fibers mediating fast sharp pain and unmyelinated C fibers mediating slow dull pain.[3] They play key roles in acute injury responses but also contribute significantly to chronic inflammatory states through processes like sensitization—whereby their threshold for activation is lowered during inflammation or injury leading to hyperalgesia/allodynia.[1] While "peripheral nociceptor" is an established physiological concept—and these cells are major therapeutic targets for analgesics—the term does not refer to a single molecule/protein/receptor but rather a class/type of primary afferent neurons defined by function and molecular profile. Thus it is not strictly correct as a canonical drug target name; instead individual molecular components expressed on these neurons—such as **Nav1.7**, **Nav1.8**, **TRPV1**, etc.—are considered canonical drug targets. > “Nociceptors remain an attractive therapeutic target: their sensitization makes an important contribution to many chronic pain states…” [4] > “Nociception refers to…specialized sensory receptors in the peripheral nervous system called nociceptors.” [8] In summary: "Peripheral nociceptor" describes a functional class/cell type rather than one discrete molecule/receptor. ---
Drugs targeting peripheral nociceptors typically act by one or more of the following mechanisms: - Blocking voltage-gated sodium channels to inhibit action potential initiation/conduction - Desensitizing TRP channels to reduce responsiveness to noxious heat/chemicals/capsaicin - Reducing inflammatory mediator release or action at the nerve terminal - Modulating neuropeptide release from nerve endings
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral nociceptor.